0000950170-23-032730.txt : 20230712
0000950170-23-032730.hdr.sgml : 20230712
20230712211514
ACCESSION NUMBER: 0000950170-23-032730
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230704
FILED AS OF DATE: 20230712
DATE AS OF CHANGE: 20230712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loose Christopher R.
CENTRAL INDEX KEY: 0001785299
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 231085619
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4/A
1
ownership.xml
4/A
X0407
4/A
2023-07-04
2023-07-07
0001703647
Frequency Therapeutics, Inc.
FREQ
0001785299
Loose Christopher R.
C/O FREQUENCY THERAPEUTICS, INC.
75 HAYDEN AVE, SUITE 300
LEXINGTON
MA
02421
false
true
false
false
Chief Scientific Officer
true
Common Stock
2023-07-04
4
M
false
150000
A
200050
D
Common Stock
2023-07-06
4
S
false
1384
0.34
D
198666
D
Restricted Stock Unit
2023-07-04
4
M
false
150000
D
Common Stock
150000
0
D
Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock.
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.33 to $0.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
The Restricted Stock Units fully vested on July 4, 2023 and do not have an expiration date.
This Form 4/A is being filed to correct (i) the vesting transaction dates, (ii) the number of Restricted Stock Units reported as vesting on Table II in columns 5 and 7, (iii) the aggregate derivatives following the transaction on Table II in column 9, (iv) the acquisition of shares on Table I in column 4, and (v) the aggregate securities following the transaction in column 5 of Table I.
/s/ James P. Abely, Attorney-in-Fact for Christopher R. Loose
2023-07-12